1. Search Result

Search Result

Results for "1903768-17-1" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-117930

    Complement System Inflammation/Immunology
    Danicopan, a selective and orally active small-molecule factor D inhibitor, inhibits alternative pathway of complement (APC) activity. Danicopan has potential to block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).